Pharmaceutical

Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit

Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.

Jul 11, 2023 - 20:00
Covid-19: Anti-inflammatory drugs do not lead to a swifter hospital exit
Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to SOC do not recover quicker compared to placebo.
Read the original article

Tags:

Previous Article

Virpax plans three trials based on platform drug delivery systems in 2024

Next Article

Israeli company bags $4.2m contract to develop cell therapy for radiation poisoning

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria 

FDA reviews Sanofi and Regeneron’s Dupixent label expan...

Nov 17, 2024

STAT+: Big Health acquires Limbix, maker of mental health app for depression in adolescents

STAT+: Big Health acquires Limbix, maker of mental heal...

Jul 14, 2023

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson gains FDA and EC approvals for TB tre...

Jul 4, 2024